Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fuji
Baxter
UBS
Queensland Health
Johnson and Johnson
Healthtrust
US Department of Justice
Deloitte

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 060730

« Back to Dashboard

NDA 060730 describes OTOCORT, which is a drug marketed by Watson Labs and Actavis Labs Fl Inc and is included in two NDAs. Additional details are available on the OTOCORT profile page.

The generic ingredient in OTOCORT is hydrocortisone; neomycin sulfate; polymyxin b sulfate. There are sixty-four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the hydrocortisone; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 060730
Tradename:OTOCORT
Applicant:Watson Labs
Ingredient:hydrocortisone; neomycin sulfate; polymyxin b sulfate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:SOLUTION/DROPS;OTICStrength1%;EQ 3.5MG BASE/ML;10,000 UNITS/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
US Department of Justice
Cipla
QuintilesIMS
Queensland Health
Deloitte
Cerilliant
McKesson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.